This site is intended only for healthcare professionals resident in the Republic of Ireland
▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. Refer to section 4.8 of the SmPC for how to report adverse reactions.
See below for an overview of NGENLA dosing and administration steps.
Refer to full Patient Information Leaflet for detailed steps.
Choose and clean your injection site
Prepare your injection
Set your prescribed dose
Inject your dose
If setting up the first use of new pen:
Step-by-step video tutorial on how to prepare and give an injection with the NGENLA prefilled pen. You can also download the complete Instructions for Use here.
Refer to full Patient Information Leaflet (PIL) for detailed steps. NGENLA 24mg pen and NGENLA 60mg pen PILs are available to download from medicines.ie
Ngenla▼ Prescribing Information
Access data on the efficacy of NGENLA.
Learn more about clinical safety data of NGENLA in children with GH deficiency.
Support for your patients throughout their treatment journey.
Legal Category: S1A
Further information is available upon request
Adverse events should be reported. Report an adverse event to your national reporting system (HPRA Pharmacovigilance)
Adverse events should also be reported to Pfizer Medical Information on 1800 633 363
Please sign in or register to gain access to information relating to Pfizer medicines and vaccines, medical conditions, patient materials and services.
This site is intended only for healthcare professionals resident in the Republic of Ireland. If you are a member of the public wishing to access information on a specific medicine, please visit https://www.medicines.ie
This website is brought to you by Pfizer Healthcare Ireland, 9 Riverwalk, National Digital Park, Citywest Business Campus, Dublin 24, Ireland. Registered in the Republic of Ireland No. 127002.
Copyright © 2023 Pfizer Limited. All rights reserved.
The information contained on this site is reserved exclusively for healthcare professionals resident in the Republic of Ireland.
I confirm that I am a healthcare professional resident in the Republic of Ireland.*
If you select 'No', you will be redirected to Pfizer.ie, where you will be able to access information on Pfizer Healthcare Ireland.
PP-UNP-IRL-0176. January 2023